Literature DB >> 22993390

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

Eric F Tewalt1, Jarish N Cohen, Sherin J Rouhani, Cynthia J Guidi, Hui Qiao, Shawn P Fahl, Mark R Conaway, Timothy P Bender, Kenneth S Tung, Anthony T Vella, Adam J Adler, Lieping Chen, Victor H Engelhard.   

Abstract

Lymphatic endothelial cells (LECs) induce peripheral tolerance by direct presentation to CD8 T cells (T(CD8)). We demonstrate that LECs mediate deletion only via programmed cell death-1 (PD-1) ligand 1, despite expressing ligands for the CD160, B- and T-lymphocyte attenuator, and lymphocyte activation gene-3 inhibitory pathways. LECs induce activation and proliferation of T(CD8), but lack of costimulation through 4-1BB leads to rapid high-level expression of PD-1, which in turn inhibits up-regulation of the high-affinity IL-2 receptor that is necessary for T(CD8) survival. Rescue of tyrosinase-specific T(CD8) by interference with PD-1 or provision of costimulation results in autoimmune vitiligo, demonstrating that LECs are significant, albeit suboptimal, antigen-presenting cells. Because LECs express numerous peripheral tissue antigens, lack of costimulation coupled to rapid high-level up-regulation of inhibitory receptors may be generally important in systemic peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993390      PMCID: PMC3520619          DOI: 10.1182/blood-2012-04-427013

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.

Authors:  M L Albert; M Jegathesan; R B Darnell
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

2.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

3.  PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.

Authors:  LauraL Carter; Lynette A Fouser; Jason Jussif; Lori Fitz; Bija Deng; Clive R Wood; Mary Collins; Tasuku Honjo; Gordon J Freeman; Beatriz M Carreno
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

4.  4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1.

Authors:  Hyeon-Woo Lee; Su-Jung Park; Beom K Choi; Hyun Hwa Kim; Kyung-Ok Nam; Byoung S Kwon
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

5.  Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.

Authors:  J Hernandez; S Aung; W L Redmond; L A Sherman
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

6.  Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim.

Authors:  Gayle M Davey; Christian Kurts; Jacques F A P Miller; Philippe Bouillet; Andreas Strasser; Andrew G Brooks; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

7.  Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.

Authors:  D Hawiger; K Inaba; Y Dorsett; M Guo; K Mahnke; M Rivera; J V Ravetch; R M Steinman; M C Nussenzweig
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

8.  Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens.

Authors:  Javier Hernández; Sandra Aung; Kristi Marquardt; Linda A Sherman
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

9.  The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.

Authors:  Gabrielle T Belz; Georg M N Behrens; Chris M Smith; Jacques F A P Miller; Claerwen Jones; Kristina Lejon; C Garrison Fathman; Scott N Mueller; Ken Shortman; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

10.  CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.

Authors:  Melanie S Vacchio; Richard J Hodes
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  115 in total

1.  Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.

Authors:  Simon Schwager; Silvana Renner; Teresa Hemmerle; Sinem Karaman; Steven T Proulx; Roman Fetz; Alexandra Michaela Golding-Ochsenbein; Philipp Probst; Cornelia Halin; Dario Neri; Michael Detmar
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 3.  Antigen archiving by lymph node stroma: A novel function for the lymphatic endothelium.

Authors:  Ross M Kedl; Beth A Tamburini
Journal:  Eur J Immunol       Date:  2015-09-10       Impact factor: 5.532

Review 4.  Role of lymphatic vasculature in regional and distant metastases.

Authors:  Simona Podgrabinska; Mihaela Skobe
Journal:  Microvasc Res       Date:  2014-07-12       Impact factor: 3.514

Review 5.  Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?

Authors:  Virginia F Borges; Traci R Lyons; Doris Germain; Pepper Schedin
Journal:  Cancer Res       Date:  2020-02-19       Impact factor: 12.701

Review 6.  Lymphangiogenesis and lymphatic vessel remodelling in cancer.

Authors:  Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

Review 7.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

Review 8.  Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.

Authors:  Susan N Thomas; Nathan A Rohner; Erin E Edwards
Journal:  Annu Rev Biomed Eng       Date:  2016-02-24       Impact factor: 9.590

Review 9.  The lymph node pre-metastatic niche.

Authors:  Jonathan P Sleeman
Journal:  J Mol Med (Berl)       Date:  2015-11       Impact factor: 4.599

10.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.